Other

Latest Articles

NxThera Raises More Than $20M In Financing

NxThera Raises More Than $20M In Financing

The company, which develops products to treat urologic conditions, said that it will use the money to seek FDA approval for one of its treatments, to introduce that treatment to the European market, and to conduct cancer research.
Analysts Expect Lackluster Sales From Target

Analysts Expect Lackluster Sales From Target

Analysts reportedly anticipate a decline in fourth-quarter sales from the Minneapolis-based retailer, due to its recent security breach, disappointing performance in Canada, and overall current weakness of the retail industry.
See More